Biosite Hints Inverness Bid Is 'Superior' to Beckman's; Firms Plan Talks

genomeweb
360dx

Biosite Hints Inverness Bid Is 'Superior' to Beckman's; Firms Plan Talks

Apr 10, 2007

NEW YORK (GenomeWeb News) — Biosite today said it will start discussions with Inverness Medical Innovations about Inverness’s offer to buy the company for $90 a share.

To read the full story....

...and receive Daily News bulletins.

Already have an account?
Login Now.

Breaking News

Exome Sequencing Helps Diagnose Primary Antibody Deficiency Patients
Innovate UK Pledges £5M in Funding to Advance Genomics Technology
Namocell Signs Distribution Deal for Single-Cell Dispenser in Japan
Fat Tissue Sequencing Leads to LincRNA With Ties to Obesity, Metabolism
Genedrive Receives UK NIHR Grant for Antibiotic-Related Hearing Loss Assay
MBS Signs German Distribution Deal for Thermal Cycler

The Scan

Threats of Synthetic Biology

A new report highlights the potential threats posed by advances in synthetic biology, NPR reports.

Deletion Is Hard to Do

A Bloomberg reporter tried to get her genetic data deleted, but found it's not so simple to do.

So Just How Many Are There?

Johns Hopkins University's Steven Salzberg and his colleagues have come up with a new estimate for the number of human genes, Nature News reports.

This Week in Genome Research

In Genome Research this week: study of intra-tumor heterogeneity, workflow resources for EPIGEN-Brazil, and more.

Main menu